Martin Shkreli
martin@martinshkreli.com
←
|
ARWR.xlsx
|
Main
JNJ-3989
fazirsiran
APOC3
ANG3
RAGE
olpasiran
A
B
C
1
Main
2
Brand
ARO-ANG3
3
Indication
Dyslipidemia
4
MOA
ANGPTL3
5
Clinical Trials
6
Phase IIb "ARCHES-2" - NCT04832971
7
8
Phase II "GATEWAY" HoFH - NCT05217667
Martin Shkreli